Europäische Marktprognose für Transfektionsreagenzien und -geräte bis 2030 – Regionale Analyse – nach Produkt (Reagenzien und Instrumente), Methode (virale Methoden, nicht-virale Methoden und Hybridmethoden), Anwendung (biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung) und Endnutzer (Akademien und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen)

BMIRE00030436 | Pages: 112 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Der europäische Markt für Transfektionsreagenzien und -geräte wurde im Jahr 2022 auf 306,04 Millionen US-Dollar geschätzt und soll bis 2030 555,46 Millionen US-Dollar erreichen; es wird geschätzt, dass er von 2022 bis 2030 eine durchschnittliche jährliche Wachstumsrate von 7,7 % verzeichnet.

Strategische Initiativen von Unternehmen treiben den europäischen Markt für Transfektionsreagenzien und -geräte an

Die Transfektion ist der komplexe Schritt im Gesamtprozess der Entwicklung eines viralen Vektors, der Adenovirus, Adeno-assoziiertes Virus und Lentivirus umfasst. Mit der Skalierung der Herstellungsprozesse muss auch die transiente Transfektion gesteigert werden. Anbieter von Prozessgeräten, Arzneimittelentwickler und Rohstofflieferanten konzentrieren sich auf Kooperationen, um kostengünstige, praktische und plattformfähige Lösungen für die schnelle Entwicklung und Skalierung von Herstellungsprozessen für virale Vektoren zu entwickeln. In kleinem Maßstab, mit geplanten Materialmengen und Transfer- und Mischzeiten, wird die Transfektion von Zellen mit mehreren Plasmiden möglich. Für die Skalierung ist Erfahrung in der Industrialisierung des Transfektionsschritts erforderlich, da die meisten Unternehmen nur über Transfektionserfahrung auf Laborebene verfügen. Das Volumen an Zellkulturmedien und Transfektionsreagenzien, das für die Skalierung des Prozesses auf ein höheres Niveau erforderlich ist, kann jedoch unpraktisch sein, was den Optimierungsbedarf unterstreicht. Dennoch ist die Ausweitung des Produktionsmaßstabs in den letzten Jahren aufgrund der steigenden Nachfrage nach viralen Vektoren üblich geworden. Angesichts der zahlreichen Herausforderungen, die mit groß angelegten Transfektionsprozessen verbunden sind, besteht der beste Ansatz zur Produktionssteigerung darin, den Prozess zu verkleinern, anstatt ihn zu skalieren. Dieser Top-down-Ansatz ermöglicht eine klare Identifizierung der Bedingungen, die sich auf den Prozess auf industrieller Ebene auswirken, wie z. B. das Volumen der Transfektionskomplexlösung. Dieser Ansatz erleichtert auch die Prozessoptimierung und Entscheidungsfindung. Die Entwicklung solcher Ansätze zur Steigerung der klein angelegten Transfektionsprozesse bietet eine Chance für das Wachstum des europäischen Marktes für Transfektionsreagenzien und -geräte.

Überblick über den europäischen Markt für Transfektionsreagenzien und -geräte

Die Region Europa ist in Großbritannien, Deutschland, Frankreich, Spanien, Italien und den Rest von Europa unterteilt. Das Vereinigte Königreich hält im Jahr 2022 den größten Marktanteil. Das Wachstum der Pharmaindustrie wird durch die im Land laufende qualitativ hochwertige Forschung und Entwicklung sowie die umfangreiche und florierende Wissensbasis im Gesundheitswesen bestimmt. Großbritannien ist eines der weltweit besten Ökosysteme für Forschung, Entwicklung, Herstellung, klinische Anwendung und Erstattung fortschrittlicher Therapeutika. Derzeit laufen im Vereinigten Königreich über 85 klinische Studien, und 70 CGT-Unternehmen streben danach, potenziell kurative Therapien zu entwickeln. Catapult ist ein Top-Unternehmen, das wesentlich zum CGT-Ökosystem im Vereinigten Königreich beigetragen hat. Es gehört zu den fünf führenden Unternehmen, die an der Entwicklung von Herstellungsprozessen für Reagenzien und Geräte im Land beteiligt sind. Das Unternehmen konzentriert sich auf die Entwicklung intelligenterer automatisierter CGT-Herstellungsprozesse, die sich mit minimalem Eingriff automatisch an veränderte Umgebungen und Prozessanforderungen anpassen können. Daher sind die Bemühungen britischer Unternehmen, ihre Produktivität zu steigern und die Endproduktkosten zu senken, die Hauptfaktoren, die das Wachstum des Zell- und Gentherapiemarkts in Großbritannien vorantreiben. Darüber hinaus hat Großbritannien aufgrund nachhaltiger und gezielter Investitionen in die Forschung eine starke Position auf dem Zell- und Gentherapiemarkt in Europa, was dem Markt zusätzlich zugutekommt.

Darüber hinaus sind in Frankreich Biopharma- und Pharmariesen wie Sanofi SA, Ipsen, Pierre Fabre, HRA Pharma und TxCell (Sangamo Therapeutics, Inc.) vertreten. Diese Unternehmen sind unter anderem an der Entwicklung von Impfstoffen und Antikörpern beteiligt, deren Produkte gefriergetrocknet werden müssen, was zur Nachfrage nach Transfektionsreagenzien und -geräten beiträgt.

Umsatz und Prognose des europäischen Marktes für Transfektionsreagenzien und -geräte bis 2030 (Mio. USD)

Segmentierung des europäischen Marktes für Transfektionsreagenzien und -geräte

Der europäische Markt für Transfektionsreagenzien und -geräte ist nach Produkt, Methode, Anwendung, Endbenutzer und Land segmentiert.

Basierend auf dem Produkt ist der europäische Markt für Transfektionsreagenzien und -geräte in Reagenzien und Instrumente unterteilt. Das Segment Reagenzien hatte 2022 einen größeren Anteil.

In Bezug auf die Methode ist der europäische Markt für Transfektionsreagenzien und -geräte in virale Methoden, nicht-virale Methoden und Hybridmethoden segmentiert. Das Segment nicht-virale Methoden hatte 2022 den größten Anteil. Das virale Segment ist in Retroviren, Adenoviren, Adeno-assoziierte Viren und Herpesviren unterteilt. Das nicht-virale Segment ist in physikalische/mechanische Methoden und chemische Methoden unterteilt. Darüber hinaus ist das Segment der physikalischen/mechanischen Methoden in Elektroporation, Mikroinjektion, biolistische Methode, Lasermethode, Magnetofektion und Sonoporation unterteilt. Auch das Segment der chemischen Methoden ist in liposomal/lipidreich und nicht liposomal/lipidreich unterteilt.

Nach Anwendung ist der europäische Markt für Transfektionsreagenzien und -geräte in biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung unterteilt. Das Segment biomedizinische Forschung hatte 2022 den größten Anteil.

Basierend auf dem Endverbraucher ist der europäische Markt für Transfektionsreagenzien und -geräte in Hochschulen und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen unterteilt. Das Segment Hochschulen und Forschungsinstitute hatte 2022 einen größeren Anteil.

Nach Ländern ist der europäische Markt für Transfektionsreagenzien und -geräte in Deutschland, Frankreich, Großbritannien, Italien, Spanien und den Rest von Europa unterteilt. Das Vereinigte Königreich dominierte im Jahr 2022 den europäischen Markt für Transfektionsreagenzien und -geräte.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc und Polyplus-Transfection SA sind einige der führenden Unternehmen auf dem europäischen Markt für Transfektionsreagenzien und -geräte.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics

4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Increasing Popularity of Cell and Gene Therapy

4.2.2 Growing Economic Burden of Cancer

4.3 Market Restraints

4.3.1 High Cost of Instruments and Consumables

4.4 Market Opportunities

4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes

4.5 Future Trends

4.5.1 Strategic Initiatives by Companies

4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Europe Market Analysis

5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030

5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis

6. Europe Transfection Reagents and Equipment Market Analysis - by Product

6.1 Reagents

6.1.1 Overview

6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

6.2 Equipment

6.2.1 Overview

6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transfection Reagents and Equipment Market Analysis - by Modality

7.1 Viral

7.1.1 Overview

7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Non-Viral

7.2.1 Overview

7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Hybrid

7.3.1 Overview

7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transfection Reagents and Equipment Market Analysis - by Application

8.1 Biomedical Research

8.1.1 Overview

8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Protein Production

8.2.1 Overview

8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Therapeutic Delivery

8.3.1 Overview

8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transfection Reagents and Equipment Market Analysis - by End Users

9.1 Academic and Research Institutes

9.1.1 Overview

9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Pharmaceutical and Biotechnological Companies

9.2.1 Overview

9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Transfection Reagents and Equipment Market -Country Analysis

10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country

10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country

10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

11.1 Overview

11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Promega Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 F. Hoffmann-La Roche Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bio-Rad Laboratories Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Mirus Bio LLC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 QIAGEN NV

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Merck KGaA

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Lonza Group AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 MaxCyte Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Polyplus-Transfection SA

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. Europe Transfection Reagents and Equipment Market Segmentation

Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality

Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral

Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral

Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method

Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method

Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users

Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country

Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market

Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List of Figures

Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030

Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)

Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)

Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)

Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)

Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)

Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transfection reagents and equipment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440